European urology最新文献_第5页

Re: EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. EAU-EANM-ESTRO-ESUR-ISUP-SIOG前列腺癌指南。

IF 25.2

European urology Pub Date : 2026-07-25 DOI: 10.1016/j.eururo.2026.07.019

Ines Santiago, Juan Gómez Rivas

引用次数: 0

Systematic Review and Meta-analysis on Renal Tumor Biopsy: Accuracy, Safety, and Impact on Clinical Decision-making. 肾肿瘤活检的系统评价和荟萃分析：准确性、安全性和对临床决策的影响。

IF 25.2

European urology Pub Date : 2026-07-24 DOI: 10.1016/j.eururo.2026.07.002

Georges Mjaess, Michele Nicolazzini, Daniele Amparore, Axel Bex, Riccardo Campi, Francesco Cei, Sabrina L Noyes, Chiara Re, Giuseppe Rosiello, Grant D Stewart, Alessandro Volpe, Carlotta Palumbo

{"title":"Systematic Review and Meta-analysis on Renal Tumor Biopsy: Accuracy, Safety, and Impact on Clinical Decision-making.","authors":"Georges Mjaess, Michele Nicolazzini, Daniele Amparore, Axel Bex, Riccardo Campi, Francesco Cei, Sabrina L Noyes, Chiara Re, Giuseppe Rosiello, Grant D Stewart, Alessandro Volpe, Carlotta Palumbo","doi":"10.1016/j.eururo.2026.07.002","DOIUrl":"https://doi.org/10.1016/j.eururo.2026.07.002","url":null,"abstract":"Background and objectives: We performed a systematic review and meta-analysis to evaluate the diagnostic accuracy, safety, and clinical impact of renal tumor biopsy (RTB) in managing renal cell carcinoma.Methods: MEDLINE, Embase, and Cochrane CENTRAL were systematically searched for studies evaluating diagnostic accuracy, complications, and clinical impact of RTB. Diagnostic performance was synthesized using hierarchical bivariate random-effects models; concordance between biopsy and surgical specimens was assessed using pooled proportions that were estimated using random-effects meta-analysis. Risk of bias was evaluated with QUADAS-2.Key findings and limitations: Overall, 103 studies were included. The pooled diagnostic yield of RTB was 90%. Summary sensitivity and specificity for malignancy were 99% and 85%, respectively. Concordance between RTB and surgical pathology was high for benign versus malignant (96%) and histological subtype (89%), but moderate for grade (four-tier: 64%; two-tier: 78%). The overall complication rate was low (3%), with negligible (<1%) Clavien-Dindo ≥3 complications and 1% bleeding events (with only two patients requiring embolization). Tumor seeding was reported only in one study with a pooled seeding proportion of 0%. RTB findings was associated with a change in clinical management in 39% of patients and avoidance of active treatment in 28%. Most studies were at high risk of bias, mainly due to patient selection and flow/timing, and were predominantly retrospective.Conclusions and clinical implications: RTB is safe and high-yield, with excellent sensitivity, high concordance for benign vs malignant and histotype, but only moderate reliability for tumor grade. RTB is therefore an important aid in refining diagnosis in patients with a renal mass and supporting individualized decision-making.","PeriodicalId":94000,"journal":{"name":"European urology","volume":" ","pages":""},"PeriodicalIF":25.2,"publicationDate":"2026-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148586383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Re: James P. Buteau, Daniel Moon, Michael T. Fahey, et al. Effect of [⁶⁸Ga]Ga-PSMA-11 PET-CT in the Diagnosis of Prostate Cancer in Men with Equivocal or Clinically High-risk Non-suspicious Findings on Multiparametric MRI (PRIMARY2): A Multicenter, Non-inferiority, Phase 3, Randomized Controlled Trial. Lancet Oncol 2026;27:839-848. 回复：James P. Buteau, Daniel Moon, Michael T. Fahey等。[68Ga]Ga-PSMA-11 PET-CT在多参数MRI （PRIMARY2）上有模棱两可或临床高风险非可疑发现的男性前列腺癌诊断中的作用：一项多中心、非劣效性、3期随机对照试验。中华医学杂志，2006;27:839-848。

IF 25.2

European urology Pub Date : 2026-07-23 DOI: 10.1016/j.eururo.2026.07.011

Alessandro Uleri, Michael Baboudjian, Giovanni Lughezzani, Guillaume Ploussard

引用次数: 0

Re: Kitamura H, Tsukamoto T, Kakehi Y, et al. Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol 2026;89:437-45. Re: Kitamura H, Tsukamoto T, Kakehi Y，等。主动监测与膀胱内卡介素-谷氨酰胺治疗第二次经尿道切除阴性的高级别T1膀胱癌：随机非劣效性3期JCOG1019试验欧洲地理，2026;89:437-45。

IF 25.2

European urology Pub Date : 2026-07-23 DOI: 10.1016/j.eururo.2026.06.026

Francesco Di Bello, Andrea Gallioli, Alberto Breda, Joan Palou

引用次数: 0

Re: Robert M. Meier, Nima Aghdam, Alan C. Beckman et al. 10-yr Survival and Toxicity Outcomes of Stereotactic Body Radiotherapy for Prostate Cancer: A Nonrandomized Clinical Trial. Eur Urol In press. http://dx.doi.org/10.1016/j.eururo.2026.04.029. Re: Robert M. Meier, Nima Aghdam, Alan C. Beckman等。立体定向放射治疗前列腺癌的10年生存率和毒性结果：一项非随机临床试验。欧元在印刷。http://dx.doi.org/10.1016/j.eururo.2026.04.029。